These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 32269145)

  • 1. Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages.
    Di Martile M; Farini V; Consonni FM; Trisciuoglio D; Desideri M; Valentini E; D'Aguanno S; Tupone MG; Buglioni S; Ercolani C; Gallo E; Amadio B; Terrenato I; Foddai ML; Sica A; Del Bufalo D
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32269145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment.
    Lucianò AM; Di Martile M; Pérez-Oliva AB; Di Caprio M; Foddai ML; Buglioni S; Mulero V; Del Bufalo D
    J Exp Clin Cancer Res; 2023 Jul; 42(1):178. PubMed ID: 37488586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor properties of triptolide: phenotype regulation of macrophage differentiation.
    Li H; Li L; Mei H; Pan G; Wang X; Huang X; Wang T; Jiang Z; Zhang L; Sun L
    Cancer Biol Ther; 2020; 21(2):178-188. PubMed ID: 31663424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
    Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
    Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of STAT3 by 2-Methoxyestradiol suppresses M2 polarization and protumoral functions of macrophages in breast cancer.
    Deswal B; Bagchi U; Santra MK; Garg M; Kapoor S
    BMC Cancer; 2024 Sep; 24(1):1129. PubMed ID: 39256694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
    Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
    BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
    Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
    Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
    Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
    J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Integrative Analysis Reveals the Association of
    Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanoma.
    Noonepalle SKR; Gracia-Hernandez M; Aghdam N; Berrigan M; Coulibaly H; Li X; Zevallos-Delgado C; Pletcher A; Weselman B; Palmer E; Knox T; Sotomayor E; Chiappinelli KB; Wardrop D; Horvath A; Shook BA; Lee N; Dritschilo A; Fernandes R; Musunuri K; Shibata M; Villagra A
    J Exp Clin Cancer Res; 2024 Sep; 43(1):263. PubMed ID: 39272209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STC1 competitively binding βPIX enhances melanoma progression via YAP nuclear translocation and M2 macrophage recruitment through the YAP/CCL2/VEGFA/AKT feedback loop.
    Ren Z; Xu Z; Chang X; Liu J; Xiao W
    Pharmacol Res; 2024 Jun; 204():107218. PubMed ID: 38768671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk of renal cell carcinoma cells and tumor-associated macrophages aggravates tumor progression by modulating muscleblind-like protein 2/B-cell lymphoma 2/beclin 1-mediated autophagy.
    He C; Li Y; Chen ZY; Huang CK
    Cytotherapy; 2023 Mar; 25(3):298-309. PubMed ID: 36244911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of IFN-γ on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms.
    Zhao W; Wang H; Zhang X; Zhang L; Pu W; Ma Y; Chen W
    BMC Pulm Med; 2024 Jan; 24(1):46. PubMed ID: 38254043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
    Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
    J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
    Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tramadol suppresses growth of orthotopic liver tumors via promoting M1 macrophage polarization in the tumor microenvironment.
    Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4205-4218. PubMed ID: 38041778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor ARF regulates tissue microenvironment and tumor growth through modulation of macrophage polarization.
    Jiménez-García L; Herranz S; Higueras MA; Luque A; Hortelano S
    Oncotarget; 2016 Oct; 7(41):66835-66850. PubMed ID: 27572316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.